Yoshitaka Miyamoto

Dr. Yoshitaka Miyamoto

Laboratory for Biomaterials and Bioengineering, Institute of Science Tokyo, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Biomaterials
Verified
Journal Article
Closed access
HYHiroshi Yukawa
Hiroshi Yukawa
MWMasaki Watanabe
Masaki Watanabe
NKNoritada Kaji
Noritada Kaji
YOYukihiro Okamoto
Yukihiro Okamoto
MTManabu Tokeshi
Manabu Tokeshi
SHShuji Hayashi
Shuji Hayashi

1 May 2010 in Biomaterials
Verified
Journal Article
Closed access
HYHiroshi Yukawa
Hiroshi Yukawa
YKYukimasa Kagami
Yukimasa Kagami
MWMasaki Watanabe
Masaki Watanabe
KOKoichi Oishi
Koichi Oishi
Yoshitaka MiyamotoYoshitaka Miyamoto
Yoshitaka Miyamoto
SHShuji Hayashi
Shuji Hayashi

1 March 2012 in Cell Transplantation
Verified
Journal Article
Closed access
Yoshitaka MiyamotoYoshitaka Miyamoto
Yoshitaka Miyamoto
KOKoichi Oishi
Koichi Oishi
HYHiroshi Yukawa
Hiroshi Yukawa
HNHirofumi Noguchi
Hirofumi Noguchi
MSMasahiro Sasaki
Masahiro Sasaki
SHShuji Hayashi
Shuji Hayashi
Adipose tissue-derived stem/progenitor cells (ASCs) have attracted attention as a cell source that replaces marrow stromal cells (MSCs); ASCs may thus have applications in both regenerative medicine and cell transplantation. These medical treatments, however, require a high-quality supply of human ASCs. Therefore, the cryopreservation methods have been improved by changing a component of a cryopreservation medium. Sericin, a protein hydrolysate (with an average molecular weight of 30 kDa) is very rich in serine. The viability and the adipogenic/osteogenic potential of human ASCs were tested after freezing in a cryopreservation medium containing sericin. After thawing, the viability of the human ASCs frozen in the cryopreservation medium was found to be more than 95%. The proliferation rate of human ASCs frozen in CELLBANKER 2, and DMEM/Ham's F-12 medium (serum free) + 10% DMSO, 0.1 mol/L maltose, and 1% sericin was higher than that of the cells frozen in the maintenance medium + 10% DMSO. The adipogenic/osteogenic differentiation capabilities of frozen human ASCs were examined by Oil Red O staining/Von Kossa's method. The human ASCs were frozen using CELLBANKER 2, and DMEM/Ham's F-12 medium (serum free) + 10% DMSO, 0.1 mol/L maltose, and 1% sericin were positive. In conclusion, the cryopreservation medium containing sericin is therefore considered to have a beneficial effect on freezing human ASCs. This serum-free cryopreservation medium should be widely used in regenerative medicine, cell transplantation, and biological research.

1 November 2006 in Cell Transplantation
Verified
Journal Article
Open access
Yoshitaka MiyamotoYoshitaka Miyamoto
Yoshitaka Miyamoto
SSSatoshi Suzuki
Satoshi Suzuki
KNKou Nomura
Kou Nomura
SEShin Enosawa
Shin Enosawa
Factors affecting cell viability, plating efficiency, and survival of hepatocytes after cryopreservation have been investigated. We focused especially on the effect of including trehalose and related oligosaccharides in the cryopreservation fluid. This was supplemented with either glucose, trehalose, maltotriose, or other sugars, in addition to dimethyl sulfoxide (10%) and first tested with primary rat hepatocytes cooled in a controlled rate freezer. After thawing, viability by trypan blue exclusion of cells frozen in oligosaccharide-supplemented medium was significantly higher than for those cryopreserved without oligosaccharides. Use of oligosaccharides with higher molecular weights resulted in greatest improvement in viability. Moreover, attachment and survival rates in plastic dishes were approximately 1.2–1.8-fold greater after freezing in the presence of di-, tri-, and tetrasaccharides. Human hepatocytes isolated from untransplantable liver showed the same tendency regarding viability, but cell adherence was not similarly improved by the addition of oligosaccharides. Possible reasons for these differences may be prior cell damage during extended cold ischemia of the human liver, donor age, or cell degradation caused by progression of fatty liver in humans, and/or species differences.

1 May 2009 in Cell Transplantation
Verified
Journal Article
Open access
PDF file
Yoshitaka MiyamotoYoshitaka Miyamoto
Yoshitaka Miyamoto
SEShin Enosawa
Shin Enosawa
TTTomoyo Takeuchi
Tomoyo Takeuchi
TTToshiaki Takezawa
Toshiaki Takezawa
Cryopreservation is generally performed on cells in suspension. In the case of adherent cells such as hepatocytes, a loss of their ability to attach is a more serious problem than a decreased viability after cryopreservation. We herein report a novel technology of direct in situ cryopreservation of cells cultured on collagen vitrigel membranes, which have excellent mechanical strength and can be easily handled by tweezers even when coated with cultured cells. Rat primary hepatocytes, mitomycin C-treated mouse fibroblasts (feeder cells for ES cells), and mouse ES cells on the feeder cells were cultured on collagen vitrigel membranes for 1 day. The membranes with cells attached were then plucked up from the dish, soaked in cryopreservation medium containing 10% dimethyl sulfoxide, frozen using a controlled-rate freezer, and transferred to liquid nitrogen. The cells cultured on plastic cell culture dishes were also frozen as controls. After storage in liquid nitrogen for periods from 1 week to 3 months, the cryopreserved membranes with the cells still attached were thawed by adding warmed culture medium. Cell viability estimated by morphology and functional staining with calcein showed significant improvement in comparison to cells cryopreserved without the collagen vitrigel membrane. The recoveries of living cells after cryopreservation were 26.7%, 76.2%, and 58.6% for rat hepatocytes, mitomycin C-treated mouse fibroblasts, and mouse ES cells on collagen vitrigel membranes, respectively. In contrast, essentially no cells at all remained on the plastic cell culture dishes after thawing. Because adherent cell storage under these conditions is very convenient, the use of this technique employing collagen vitrigel membranes should be generally applicable to the cryopreservation of adherent cells that are otherwise problematic to store as frozen stocks.